Ro4938581
Ro4938581 is a pharmacological compound that acts as a positive allosteric modulator at the GABAA receptor. It is a derivative of the benzodiazepine class of drugs, with a unique chemical structure that distinguishes it from other benzodiazepines.
Chemistry[edit | edit source]
Ro4938581 is a benzodiazepine derivative, meaning it is structurally related to drugs such as diazepam and alprazolam. However, unlike these drugs, Ro4938581 has a unique chemical structure that includes a pyrazoloquinolinone core, which is not found in other benzodiazepines. This unique structure is thought to contribute to its distinct pharmacological properties.
Pharmacology[edit | edit source]
Ro4938581 acts as a positive allosteric modulator at the GABAA receptor, a type of ionotropic receptor that is widely distributed throughout the central nervous system. By enhancing the activity of this receptor, Ro4938581 can increase the inhibitory effects of the neurotransmitter GABA, which can lead to sedative, anxiolytic, and anticonvulsant effects.
Clinical Use[edit | edit source]
While Ro4938581 has been studied in preclinical trials, it has not yet been approved for use in humans. However, its unique pharmacological properties make it a promising candidate for the treatment of conditions such as anxiety disorders, insomnia, and epilepsy.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
